Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases

Biana Godin; Jason H. Sakamoto; Rita E. Serda; Alessandro Grattoni; Ali Bouamrani; Mauro Ferrari

doi:10.1016/j.tips.2010.01.003

Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases

Biana Godin, Jason H. Sakamoto, Rita E. Serda, Alessandro Grattoni, Ali Bouamrani, Mauro Ferrari

Research output: Contribution to journal › Review article

154 Scopus citations

Abstract

Nanomedicine is an emerging field that utilizes nanotechnology concepts for advanced therapy and diagnostics. This convergent discipline merges research areas such as chemistry, biology, physics, mathematics and engineering. It therefore bridges the gap between molecular and cellular interactions, and has the potential to revolutionize medicine. This review presents recent developments in nanomedicine research poised to have an important impact on the treatment of cardiovascular disease. This will occur through improvement of the diagnosis and therapy of cardiovascular disorders as atherosclerosis, restenosis and myocardial infarction. Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques.

Original language	English (US)
Pages (from-to)	199-205
Number of pages	7
Journal	Trends in Pharmacological Sciences
Volume	31
Issue number	5
DOIs	https://doi.org/10.1016/j.tips.2010.01.003
State	Published - May 2010

ASJC Scopus subject areas

Toxicology
Pharmacology

Access to Document

10.1016/j.tips.2010.01.003

Fingerprint Dive into the research topics of 'Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases'. Together they form a unique fingerprint.

Cite this

@article{9f594c47ae8f4d1690006ec8fe590dc2,

title = "Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases",

abstract = "Nanomedicine is an emerging field that utilizes nanotechnology concepts for advanced therapy and diagnostics. This convergent discipline merges research areas such as chemistry, biology, physics, mathematics and engineering. It therefore bridges the gap between molecular and cellular interactions, and has the potential to revolutionize medicine. This review presents recent developments in nanomedicine research poised to have an important impact on the treatment of cardiovascular disease. This will occur through improvement of the diagnosis and therapy of cardiovascular disorders as atherosclerosis, restenosis and myocardial infarction. Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques.",

author = "Biana Godin and Sakamoto, {Jason H.} and Serda, {Rita E.} and Alessandro Grattoni and Ali Bouamrani and Mauro Ferrari",

year = "2010",

month = may,

doi = "10.1016/j.tips.2010.01.003",

language = "English (US)",

volume = "31",

pages = "199--205",

journal = "Trends in Pharmacological Sciences",

issn = "0165-6147",

publisher = "Elsevier Limited",

number = "5",

}

TY - JOUR

T1 - Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases

AU - Godin, Biana

AU - Sakamoto, Jason H.

AU - Serda, Rita E.

AU - Grattoni, Alessandro

AU - Bouamrani, Ali

AU - Ferrari, Mauro

PY - 2010/5

Y1 - 2010/5

N2 - Nanomedicine is an emerging field that utilizes nanotechnology concepts for advanced therapy and diagnostics. This convergent discipline merges research areas such as chemistry, biology, physics, mathematics and engineering. It therefore bridges the gap between molecular and cellular interactions, and has the potential to revolutionize medicine. This review presents recent developments in nanomedicine research poised to have an important impact on the treatment of cardiovascular disease. This will occur through improvement of the diagnosis and therapy of cardiovascular disorders as atherosclerosis, restenosis and myocardial infarction. Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques.

AB - Nanomedicine is an emerging field that utilizes nanotechnology concepts for advanced therapy and diagnostics. This convergent discipline merges research areas such as chemistry, biology, physics, mathematics and engineering. It therefore bridges the gap between molecular and cellular interactions, and has the potential to revolutionize medicine. This review presents recent developments in nanomedicine research poised to have an important impact on the treatment of cardiovascular disease. This will occur through improvement of the diagnosis and therapy of cardiovascular disorders as atherosclerosis, restenosis and myocardial infarction. Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques.

UR - http://www.scopus.com/inward/record.url?scp=77952551701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952551701&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2010.01.003

DO - 10.1016/j.tips.2010.01.003

M3 - Review article

C2 - 20172613

AN - SCOPUS:77952551701

VL - 31

SP - 199

EP - 205

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 5

ER -